4//SEC Filing
Sumner Michael John 4
Accession 0001055726-24-000029
CIK 0001055726other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:06 PM ET
Size
7.6 KB
Accession
0001055726-24-000029
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-15+2,386→ 5,302 total - Exercise/Conversion
Restricted Stock Unit
2024-05-15−2,386→ 4,770 total→ Common Stock (2,386 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares will vest on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001936799
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:06 PM ET
- Size
- 7.6 KB